
Results from a new study researching treatment for dyskinesia has offered hope that it may be treatable in people with …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

